NCT07375069

Brief Summary

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Oct 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2022Oct 2027

Study Start

First participant enrolled

October 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 29, 2026

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Expected
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

January 21, 2026

Last Update Submit

March 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diabetes treatment adherence according to the most recent European Guidelines

    Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.

    12-24-36-48 months

Interventions

Data collection on diabetes therapy and follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive diabetic patients attending the outpatient clinics, in primary and secondary prevention of cardiovascular disease.

You may qualify if:

  • Age ≥ 18 years;
  • Diagnosis of type 2 diabetes mellitus (T2DM);
  • Stable clinical conditions
  • Outpatient settings
  • Ability to understand the study procedures and provide written informed consent.

You may not qualify if:

  • Patients with type 1 diabetes mellitus;
  • Active participation in interventional studies;
  • Any condition that may put the patient at risk by participating in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federico II University of Naples, Department of Advanced Biomedical Sciences

Naples, Napoli, 80131, Italy

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Pasquale Perrone Filardi

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
4 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 21, 2026

First Posted

January 29, 2026

Study Start

October 1, 2022

Primary Completion

October 31, 2023

Study Completion (Estimated)

October 31, 2027

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations